TNF and psoriasis: The small molecule drug apremilast (marketed under the trade name Otezla® by Amgen Inc., Thousand Oaks, CA), a selective inhibitor of the enzyme phosphodiesterase 4 (PDE4) that inhibits production of TNF-α by rheumatoid synovial cells, among others, is increasingly being used to treat psoriasis [4].